Abstract:Diabetes poses a serious threat to the health of people around the world. Therefore, in 2021, the World Health Organisation launched the Global Diabetes Compact, an initiative aimed at improving the management and prevention of diabetes. The rapid growth in the number of diabetic patients has increased the need for insulin. Rapid-acting human insulin analogues, including insulin aspart, improve the efficacy of insulin therapy. Methods for insulin aspart production include its biosynthesis in the proinsulin form in Escherichia coli . However, the yield of the recombinant protein largely depends on the optimisation of the production process. The aim of the study was to optimise the induction conditions for an E. coli strain expressing recombinant proinsulin aspart through applying the Design of Experiment (DoE) approach to enhance bacterial cell productivity. Materials and methods. The study focused on a strain of E. coli producing proinsulin aspart. The authors planned the experiment using MODDE software and the reduced face-centred central composite design (CCF) enabling the assessment of factor interactions and the creation of design spaces. The authors carried out fermentations of the producing strain in a 5 L Biostat® B bioreactor and measured proinsulin aspart concentrations by capillary gel electrophoresis. The results were analysed using GraphPad Prism 6. Results. Using the DoE approach, the authors optimised the conditions for the growth of the producer strain and the biosynthesis of proinsulin aspart. Based on data from response surface plots for wet biomass concentration, specific productivity, and volumetric productivity, as well as plotted models, the authors established design spaces for the induction of proinsulin aspart expression in E. coli . The plotted models demonstrated high predictive power and high reproducibility of the results. The authors successfully validated the induction process for the synthesis of proinsulin aspart in a bioreactor under optimised conditions. The volumetric productivity of the strain producing proinsulin aspart increased from 3.06±0.16 g/L (conventional conditions) to 4.93±0.80 g/L (optimised conditions). Conclusions. The authors achieved a 60% increase in the volumetric yield of proinsulin aspart. The study results may be used to intensify the industrial production of insulin aspart.

Optimization of Expression Condition of Recombinant Human Insulin B27K-DTrI Precursor in P.pastoris

High-density Expression of Recombinant Porcine Insulin Precursor by Pichia pastoris

Cloning, Expression, and Purification of Recombinant Human-Insulin Analogue Gene in E.coli

Efficient generation of multi-copy strains for optimizing secretory expression of porcine insulin precursor in yeast Pichia pastoris.

Optimization of medium composition and inducing pH of porcine insulin precursor fermentation by recombinant Pichia pastoris using of central composite design

Culture Conditions Affecting High Level Expression of Porcine Insulin Precursor (PIP) by Recombinant Pichia Pastoris in High Cell Density Fermentation

Metabolic Data Association Analysis and Modeling for Recombinant Porcine Insulin Precursor Expression in Genetically Engineered Pichia Pastoris

Studies of the Growth Kinetics and Induction Strategy with a Strain of Recombinant Yeast Pichia Pastoris Expressing the Human Insulin Gene

Application of simple fed-batch technique to high-level secretory production of insulin precursor using Pichia pastoris with subsequent purification and conversion to human insulin

Optimisation of induction conditions for a bacterial strain producing proinsulin aspart

Production of recombinant human insulin from a promising Pseudomonas fluorescens cell factory and its kinetic modeling

RSM optimization of HSA/IL1Ra in Pichia pastoris overexpression strain and study of its in vivo activity in reducing hyperglycemia of GK rats.

Optimization of Cultivation Conditions of Recombinant Escherichia Coli Strain Expressing Human Anticoagulant Protein(rHAP)

Optimization of Fermentation Process for Recombinant Escherichia coli Expression of Phospholipase C

Effect of Temperature on the Secretory Expression of Porcine Insulin Precursor and Physiological Characterization of Multi-copy P.pastoris

A Simple Unstructured Model-Based Control for Efficient Expression of Recombinant Porcine Insulin Precursor by Pichia Pastoris

Human Proinsulin C-Peptide from A Precursor Overexpressed in Pichia Pastoris

Expression and purification of recombinant human insulin from E. coli 20 strain

N-Terminal Heterogeneity and Purification of Insulin Precursor Expressed in Pichia Pasoris

High-Level Expression and Purification of Recombinant Heparinase Ⅰ in Escherichia Coli

Production of Human Insulin in an E. Coli System with Met-Lys-human Proinsulin As the Expressed Precursor.